KYTHERA Biopharmaceuticals announced the pricing of its initial public offering of 4,400,000 shares of its common stock at a price to the public of $16.00 per share. The shares of KYTHERA’s common stock will trade on the NASDAQ under the symbol “KYTH.” KYTHERA has granted the underwriters a 30-day option to purchase
up to an additional 660,000 shares of common stock to cover over-allotments. The offering is expected to close on October 16, 2012
J.P. Morgan Securities Goldman Sachs are acting as joint book-running managers for the offering. Leerink Swann is acting as lead co-manager and Lazard Capital Markets is acting as co-manager.